Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells
Hannah Donnelly,Ewan Ross,Yinbo Xiao,Rio Hermantara,Aqeel Taqi,W. Sebastian Doherty-Boyd,Jennifer Cassels,Penelope. M. Tsimbouri,Karen M Dunn,Jodie Hay,Annie Cheng,Nikhil Jain,Christopher West,Helen Wheadon,Alison M Michie,Bruno Peault,Adam G. West,Manuel Salmeron-Sanchez,Matthew J. Dalby
DOI: https://doi.org/10.1101/2022.07.28.501818
2024-03-05
Abstract:Long-term reconstituting haematopoietic stem cells (LT-HSCs) are used to treat blood disorders via allogeneic stem cell transplantation (alloSCT), to engraft and repopulate the blood system. The very low abundance of LT-HSCs and their rapid differentiation during culture hinders their clinical utility. Previous developments using stromal feeder layers, defined media cocktails, and bioengineering have enabled HSC expansion in culture, but of mostly short-term HSCs (ST-HSC) and progenitor populations at the expense of naïve LT-HSCs. Here, we report the creation of a bioengineered LT-HSC maintenance niche that recreates physiological extracellular matrix organisation, using soft collagen type-I hydrogels to drive nestin expression in perivascular stromal cells (PerSCs or pericytes). We demonstrate that nestin, which is expressed by HSC-supportive bone marrow stromal cells, is cytoprotective and, via regulation of metabolism, is important for HIF-1α expression in PerSCs. When CD34 HSCs were added to the bioengineered niches comprising nestin/HIF-1α expressing PerSCs, LT-HSC numbers were maintained with normal clonal and reconstitution potential, without media supplementation. We provide proof-of-concept that our bioengineered niches can support the survival of CRISPR edited HSCs. Successful editing of LT-HSCs ex vivo can have potential impact on the treatment of blood disorders.
Bioengineering